Mutations in the Presenilin genes (PSEN1 and PSEN2) account for > 80% of all identified causative mutations in familial AD, highlighting the importance of Presenilin (PS) in AD pathogenesis. The gene discussed is PRB2; the disease is Alzheimer disease.